Prospective genomic surveillance of methicillin-resistant


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 28 7 2020
Statut: ppublish

Résumé

BackgroundMandatory reporting of methicillin-resistant

Identifiants

pubmed: 30696529
doi: 10.2807/1560-7917.ES.2019.24.4.1800215
pmc: PMC6351993
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201344/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N029399/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S00291X/1
Pays : United Kingdom

Références

MMWR Morb Mortal Wkly Rep. 2001 Oct 26;50(42):919-22
pubmed: 11699844
Bioinformatics. 2005 Feb 15;21(4):456-63
pubmed: 15608047
J Clin Microbiol. 2005 Jan;43(1):502-5
pubmed: 15635028
J Clin Microbiol. 2005 May;43(5):2384-90
pubmed: 15872271
J Hosp Infect. 2006 May;63 Suppl 1:S1-44
pubmed: 16581155
Clin Microbiol Rev. 2010 Jul;23(3):616-87
pubmed: 20610826
J Clin Microbiol. 2011 Jan;49(1):433-6
pubmed: 21068288
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
J Antimicrob Chemother. 2011 Dec;66(12):2685-8
pubmed: 21948966
J Antimicrob Chemother. 2012 Apr;67(4):802-9
pubmed: 22223229
Br J Nurs. 2011 Dec 8-2012 Jan 11;20(22):1418, 1420-4
pubmed: 22241489
J Antimicrob Chemother. 2012 Oct;67(10):2338-41
pubmed: 22687894
N Engl J Med. 2012 Jun 14;366(24):2267-75
pubmed: 22693998
Lancet Infect Dis. 2013 Feb;13(2):130-6
pubmed: 23158674
J Hosp Infect. 2013 Jan;83(1):14-21
pubmed: 23164609
Genome Res. 2013 Apr;23(4):653-64
pubmed: 23299977
JAMA Intern Med. 2013 Aug 12;173(15):1397-404
pubmed: 23857503
Clin Infect Dis. 2014 Mar;58(5):609-18
pubmed: 24336829
Proc Natl Acad Sci U S A. 2014 May 6;111(18):6738-43
pubmed: 24753569
J Antimicrob Chemother. 2014 Aug;69(8):2238-45
pubmed: 24788657
Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1757-62
pubmed: 24816900
Int J Med Microbiol. 2014 Nov;304(8):1118-22
pubmed: 25200859
J Clin Microbiol. 2014 Dec;52(12):4305-8
pubmed: 25297335
Euro Surveill. 2014 Dec 11;19(49):null
pubmed: 25523972
Eur J Clin Microbiol Infect Dis. 2015 May;34(5):935-42
pubmed: 25575950
Clin Microbiol Infect. 2015 Apr;21(4):347.e1-4
pubmed: 25658529
BMJ Open. 2015 Mar 26;5(3):e006596
pubmed: 25814495
Open Forum Infect Dis. 2015 Mar 12;2(2):ofv035
pubmed: 26380336
Genome Res. 2016 Feb;26(2):263-70
pubmed: 26672018
J Infect Dis. 2016 Aug 1;214(3):447-53
pubmed: 27122590
J Hosp Infect. 2016 Dec;94(4):401-404
pubmed: 27729168
Microb Genom. 2016 Nov 30;2(11):e000093
pubmed: 28348833
Microb Genom. 2016 Aug 25;2(8):e000083
pubmed: 28348874
J Infect Dis. 2017 Feb 15;215(suppl_1):S71-S77
pubmed: 28375517
Sci Transl Med. 2017 Oct 25;9(413):
pubmed: 29070701

Auteurs

Michelle S Toleman (MS)

University of Cambridge, Department of Medicine, Cambridge, United Kingdom.
Wellcome Sanger Institute, Hinxton, United Kingdom.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

Sandra Reuter (S)

University of Freiburg, Institute for Infection Prevention and Hospital Epidemiology, Freiburg, Germany.

Dorota Jamrozy (D)

Wellcome Sanger Institute, Hinxton, United Kingdom.

Hayley J Wilson (HJ)

University of Cambridge, Department of Medicine, Cambridge, United Kingdom.

Beth Blane (B)

University of Cambridge, Department of Medicine, Cambridge, United Kingdom.

Ewan M Harrison (EM)

University of Cambridge, Department of Medicine, Cambridge, United Kingdom.
Wellcome Sanger Institute, Hinxton, United Kingdom.

Francesc Coll (F)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Russell J Hope (RJ)

Public Health England, National Infection Service, Colindale, London, United Kingdom.

Angela Kearns (A)

Public Health England, National Infection Service, Colindale, London, United Kingdom.

Julian Parkhill (J)

Wellcome Sanger Institute, Hinxton, United Kingdom.

Sharon J Peacock (SJ)

University of Cambridge, Department of Medicine, Cambridge, United Kingdom.
Wellcome Sanger Institute, Hinxton, United Kingdom.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
London School of Hygiene and Tropical Medicine, London, United Kingdom.

M Estée Török (ME)

University of Cambridge, Department of Medicine, Cambridge, United Kingdom.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, United Kingdom.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH